These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2568143)

  • 1. Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone.
    Carli M; Prontera C; Samanin R
    Br J Pharmacol; 1989 Apr; 96(4):829-36. PubMed ID: 2568143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin 1A receptor agonist.
    Carli M; Samanin R
    Psychopharmacology (Berl); 1988; 94(1):84-91. PubMed ID: 2894704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone.
    Fletcher PJ; Davies M
    Br J Pharmacol; 1990 Mar; 99(3):519-25. PubMed ID: 2139586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological suppression of the median raphe nucleus with serotonin1A agonists, 8-OH-DPAT and buspirone, produces hippocampal theta rhythm in the rat.
    Vertes RP; Kinney GG; Kocsis B; Fortin WJ
    Neuroscience; 1994 May; 60(2):441-51. PubMed ID: 8072690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection.
    Higgins GA; Jones BJ; Oakley NR
    Psychopharmacology (Berl); 1992; 106(2):261-7. PubMed ID: 1347954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of intracerebral and systemic administration of buspirone in the forced swimming test: involvement of a metabolite.
    Cervo L; Grignaschi G; Samanin R
    Life Sci; 1988; 43(25):2095-102. PubMed ID: 2905409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of midazolam and 5-HT1A receptor agonists.
    Stefański R; Pałejko W; Bidziński A; Kostowski W; Płaźnik A
    Neuropharmacology; 1993 Oct; 32(10):977-85. PubMed ID: 7905194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone.
    Davis M; Cassella JV; Kehne JH
    Psychopharmacology (Berl); 1988; 94(1):14-20. PubMed ID: 2894698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of serotonergic affect control.
    Kennett GA
    Adv Exp Med Biol; 1991; 294():231-43. PubMed ID: 1685293
    [No Abstract]   [Full Text] [Related]  

  • 10. Anxiolytic effect of the 5-HT1A compounds 8-hydroxy-2-(di-n-propylamino) tetralin and ipsapirone in the social interaction paradigm: evidence of a presynaptic action.
    Picazo O; López-Rubalcava C; Fernández-Guasti A
    Brain Res Bull; 1995; 37(2):169-75. PubMed ID: 7606493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
    Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
    Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural and biochemical consequences following activation of 5HT1-like and GABA receptors in the dorsal raphé nucleus of the rat.
    Higgins GA; Bradbury AJ; Jones BJ; Oakley NR
    Neuropharmacology; 1988 Oct; 27(10):993-1001. PubMed ID: 2467224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant-like effects of buspirone mediated by the 5-HT1A post-synaptic receptors in the learned helplessness paradigm.
    Martin P; Tissier MH; Adrien J; Puech AJ
    Life Sci; 1991; 48(26):2505-11. PubMed ID: 1828519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional topography of brain serotonergic pathways in the rat.
    Hillegaart V
    Acta Physiol Scand Suppl; 1991; 598():1-54. PubMed ID: 1832809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity.
    Sharp T; Bramwell SR; Clark D; Grahame-Smith DG
    J Neurochem; 1989 Jul; 53(1):234-40. PubMed ID: 2470860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 5-HT1A agonists on stress-induced deficit in open field locomotor activity of rats: evidence that this model identifies anxiolytic-like activity.
    Carli M; Prontera C; Samanin R
    Neuropharmacology; 1989 May; 28(5):471-6. PubMed ID: 2566948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug.
    VanderMaelen CP; Matheson GK; Wilderman RC; Patterson LA
    Eur J Pharmacol; 1986 Sep; 129(1-2):123-30. PubMed ID: 2876903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alnespirone and buspirone have anxiolytic-like effects in a conflict procedure in rats by stimulating 5-HT(1A) receptors.
    Cervo L; Munoz C; Bertaglia A; Samanin R
    Behav Pharmacol; 2000 Apr; 11(2):153-60. PubMed ID: 10877120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine.
    Blier P; Serrano A; Scatton B
    Synapse; 1990; 5(2):120-33. PubMed ID: 2137943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.